4,359 Shares in Ryan Specialty Holdings, Inc. (NYSE:RYAN) Acquired by Stephens Inc. AR

Stephens Inc. AR bought a new position in Ryan Specialty Holdings, Inc. (NYSE:RYAN) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 4,359 shares of the company’s stock, valued at approximately $289,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. GAMMA Investing LLC lifted its holdings in Ryan Specialty by 96.4% in the 2nd quarter. GAMMA Investing LLC now owns 605 shares of the company’s stock worth $35,000 after purchasing an additional 297 shares during the last quarter. Crewe Advisors LLC acquired a new position in shares of Ryan Specialty during the second quarter worth approximately $39,000. Rothschild Investment LLC acquired a new position in shares of Ryan Specialty during the second quarter worth approximately $87,000. Signaturefd LLC lifted its holdings in shares of Ryan Specialty by 12.3% during the third quarter. Signaturefd LLC now owns 1,347 shares of the company’s stock worth $89,000 after buying an additional 148 shares during the last quarter. Finally, Northwestern Mutual Wealth Management Co. lifted its holdings in shares of Ryan Specialty by 1,688.7% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 2,844 shares of the company’s stock worth $165,000 after buying an additional 2,685 shares during the last quarter. 84.82% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research analysts have recently commented on RYAN shares. Wells Fargo & Company upped their price target on Ryan Specialty from $63.00 to $70.00 and gave the stock an “equal weight” rating in a report on Thursday, October 10th. UBS Group upped their price target on Ryan Specialty from $67.00 to $76.00 and gave the stock a “buy” rating in a report on Tuesday, August 13th. The Goldman Sachs Group upped their target price on Ryan Specialty from $64.00 to $72.00 and gave the company a “neutral” rating in a research note on Wednesday, October 9th. BMO Capital Markets upgraded Ryan Specialty from a “market perform” rating to an “outperform” rating and upped their target price for the company from $65.00 to $75.00 in a research note on Tuesday, September 24th. Finally, Citigroup upped their target price on Ryan Specialty from $56.00 to $62.00 and gave the company a “neutral” rating in a research note on Tuesday, July 23rd. One analyst has rated the stock with a sell rating, five have given a hold rating and five have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $70.33.

Insider Transactions at Ryan Specialty

In other news, EVP Jeremiah Rawlins Bickham sold 26,233 shares of the stock in a transaction on Wednesday, August 14th. The stock was sold at an average price of $65.18, for a total transaction of $1,709,866.94. Following the sale, the executive vice president now owns 24,845 shares in the company, valued at approximately $1,619,397.10. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other news, Director Nicholas Dominic Cortezi sold 1,500 shares of the stock in a transaction on Thursday, August 15th. The stock was sold at an average price of $65.02, for a total transaction of $97,530.00. Following the sale, the director now owns 25,123 shares in the company, valued at approximately $1,633,497.46. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Jeremiah Rawlins Bickham sold 26,233 shares of the stock in a transaction on Wednesday, August 14th. The stock was sold at an average price of $65.18, for a total value of $1,709,866.94. Following the sale, the executive vice president now owns 24,845 shares in the company, valued at $1,619,397.10. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 107,136 shares of company stock worth $6,960,032. Insiders own 11.10% of the company’s stock.

Ryan Specialty Stock Performance

Ryan Specialty stock opened at $71.14 on Friday. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01. The stock has a fifty day moving average price of $67.43 and a two-hundred day moving average price of $60.93. Ryan Specialty Holdings, Inc. has a 52-week low of $41.49 and a 52-week high of $73.10. The firm has a market capitalization of $18.63 billion, a P/E ratio of 92.39, a P/E/G ratio of 1.52 and a beta of 0.62.

Ryan Specialty (NYSE:RYAN) last released its quarterly earnings data on Wednesday, October 30th. The company reported $0.41 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.41. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. The firm had revenue of $604.69 million during the quarter, compared to analyst estimates of $602.04 million. During the same period in the prior year, the company posted $0.32 earnings per share. The business’s revenue for the quarter was up 20.5% compared to the same quarter last year. As a group, analysts anticipate that Ryan Specialty Holdings, Inc. will post 1.81 EPS for the current fiscal year.

Ryan Specialty Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, November 26th. Shareholders of record on Tuesday, November 12th will be paid a dividend of $0.11 per share. The ex-dividend date of this dividend is Tuesday, November 12th. This represents a $0.44 annualized dividend and a yield of 0.62%. Ryan Specialty’s dividend payout ratio is currently 57.14%.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.